2. Academic Validation
  3. New Substituted Cyanoindoline Derivatives as MAP3K14 Kinase Inhibitors for the Treatment of Cancer and Autoimmune Disorders

New Substituted Cyanoindoline Derivatives as MAP3K14 Kinase Inhibitors for the Treatment of Cancer and Autoimmune Disorders

  • ACS Med Chem Lett. 2017 Aug 17;8(9):908-910. doi: 10.1021/acsmedchemlett.7b00330.
Robert B Kargbo 1
Affiliations

Affiliation

  • 1 AMRI, Albany, New York 12212-5098, United States.
PMID: 28947934 DOI: 10.1021/acsmedchemlett.7b00330
Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z